{"id":20,"date":"2018-08-31T08:43:31","date_gmt":"2018-08-31T08:43:31","guid":{"rendered":"http:\/\/fertiga.com\/?page_id=20"},"modified":"2026-06-04T10:12:33","modified_gmt":"2026-06-04T08:12:33","slug":"increased-live-birth-rate-2","status":"publish","type":"page","link":"https:\/\/fertiga.com\/es\/increased-live-birth-rate-2\/","title":{"rendered":"Para los proveedores de atenci\u00f3n m\u00e9dica"},"content":{"rendered":"<\/p>\n<p class=\"has-text-align-center\"><em>No todos los ovocitos son iguales\u2026 pero ahora puedes saber cu\u00e1les tendr\u00e1n m\u00e1s probabilidades de desarrollarse.<\/em><\/p>\n<p>\n\n\n<p class=\"wp-block-paragraph\">Aurora niPCT\u2122 es la primera prueba <strong>no invasiva<\/strong> con eficacia cl\u00ednica comprobada que se centra en lo verdaderamente importante: el potencial biol\u00f3gico del ovocito. Mediante el an\u00e1lisis de las c\u00e9lulas del c\u00famulo que rodean y sostienen naturalmente al \u00f3vulo, Aurora niPCT\u2122 decodifica las se\u00f1ales moleculares de mayor potencial. A diferencia de las pruebas de imagen o los cultivos celulares, <strong>no realiza conjeturas, sino mediciones<\/strong>. A diferencia de las pruebas gen\u00e9ticas invasivas, <strong>no causa da\u00f1o<\/strong>. Y a diferencia de muchas herramientas emergentes, ya est\u00e1 <strong>validada en la pr\u00e1ctica cl\u00ednica<\/strong>, donde ha incrementado significativamente las tasas de embarazo y nacimientos vivos en la primera transferencia.<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\">La <strong>precisi\u00f3n de Aurora niPCT\u2122 para un nacimiento vivo<\/strong> en pacientes estimuladas con<\/h2>\n\n\n\n<div class=\"stats-container\">\n  <div class=\"stat-item\">\n    <div class=\"stat-box\">\n      <span class=\"stat-text\">hMG <span class=\"small-brackets\">(p. ej., Menopur, Meriofert)<\/span><\/span>\n      <span class=\"stat-bubble\">\n        80%*\n        <svg class=\"bubble-ring\" viewbox=\"0 0 100 100\">\n          <circle cx=\"50\" cy=\"50\" r=\"48\" stroke=\"#528C9E\" stroke-width=\"4\" fill=\"none\"\/>\n        <\/svg>\n      <\/span>\n    <\/div>\n  <\/div>\n  <div class=\"stat-item\">\n    <div class=\"stat-box\">\n      <span class=\"stat-text\">rFSH <span class=\"small-brackets\">(por ejemplo, Gonal-F, Rekovelle, Bemfola, Puregon)<\/span><\/span>\n      <span class=\"stat-bubble\">\n        70%**\n        <svg class=\"bubble-ring\" viewbox=\"0 0 100 100\">\n          <circle cx=\"50\" cy=\"50\" r=\"48\" stroke=\"#528C9E\" stroke-width=\"4\" fill=\"none\"\/>\n        <\/svg>\n      <\/span>\n    <\/div>\n  <\/div>\n  <div class=\"stat-item\">\n    <div class=\"stat-box\">\n      <span class=\"stat-text\">rFSH+rLH <span class=\"small-brackets\">(Pergoveris)<\/span><\/span>\n      <span class=\"stat-bubble\">\n        88%**\n        <svg class=\"bubble-ring\" viewbox=\"0 0 100 100\">\n          <circle cx=\"50\" cy=\"50\" r=\"48\" stroke=\"#528C9E\" stroke-width=\"4\" fill=\"none\"\/>\n        <\/svg>\n      <\/span>\n    <\/div>\n  <\/div>\n<\/div>\n\n<!-- New description box -->\n<div class=\"description-box\">\n  <p>\n    * despu\u00e9s de analizar las c\u00e9lulas del c\u00famulo de &gt; 1000 ovocitos (Van Vaerenbergh et al., 2021; Adriaenssens et al., 2019); ** despu\u00e9s de analizar las c\u00e9lulas del c\u00famulo de &gt; 1000 ovocitos (Adriaenssens et al., 2025).\n  <\/p>\n<\/div>\n\n<style>\n.stats-container {\n  display: flex;\n  flex-direction: column;\n  gap: 25px;\n  max-width: 650px;\n  margin: 50px auto;\n}\n\n.stat-item {\n  display: flex;\n  justify-content: center;\n}\n\n.stat-box {\n  position: relative;\n  display: flex;\n  align-items: center;\n  height: 60px;\n  background: linear-gradient(to right, #F4AD31 0%, rgba(244,173,49,0) 100%);\n  border-radius: 15px;\n  padding: 0 20px;\n  width: 75%;\n  max-width: 500px;\n}\n\n.stat-text {\n  font-size: 20px;\n  font-weight: bold;\n  color: #333;\n  line-height: 30px;\n  flex: 1;\n}\n\n\/* Smaller font for text in brackets *\/\n.small-brackets {\n  font-size: 14px;\n  font-weight: normal;\n  color: #555;\n}\n\n.stat-bubble {\n  position: absolute;\n  right: -25px;\n  top: 50%;\n  transform: translateY(-50%);\n  width: 80px;\n  height: 80px;\n  background-color: white;\n  color: #528C9E;\n  font-size: 24px;\n  font-weight: bold;\n  display: flex;\n  justify-content: center;\n  align-items: center;\n  border-radius: 50%;\n  box-shadow: 0 2px 6px rgba(0,0,0,0.2);\n}\n\n.bubble-ring {\n  position: absolute;\n  top: 0;\n  left: 0;\n  width: 100%;\n  height: 100%;\n  pointer-events: none;\n}\n\n.description-box {\n  max-width: 500px;\n  margin: -45px auto 0; \/* closer to stats *\/\n  padding: 8px 12px;\n  border-radius: 0 0 12px 12px; \/* rounded only at bottom *\/\n  text-align: center;\n  font-size: 11px;\n  color: #333;\n  background-color: #fff;\n}\n<\/style>\n\n\n<h2 class=\"wp-block-heading\">Resultados de nuestros estudios<\/h2>\n<p><strong>Mayor tasa de nacimientos vivos<\/strong> <strong>y tasa<\/strong> <strong>de embarazos cl\u00ednicos con la transferencia de un solo espermatozoide (SET)<\/strong><\/p>\n<figure class=\"wp-block-image alignright size-full is-resized\"><a href=\"https:\/\/fertiga.com\/wp-content\/uploads\/2025\/09\/D3-and-D5.png\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1039 alignleft\" src=\"https:\/\/fertiga.com\/wp-content\/uploads\/2025\/09\/D3-and-D5.png\" alt=\"clinical pregnancy rate increased significantly from 27 % to 63 % in the first fresh transfer cycle. Compared to day 5 SET \u2014 from 43 % to 63 %. Moreover, significant increase in live birth rate was proven between day 3 transfers.\" width=\"289\" height=\"222\" srcset=\"https:\/\/fertiga.com\/wp-content\/uploads\/2025\/09\/D3-and-D5.png 962w, https:\/\/fertiga.com\/wp-content\/uploads\/2025\/09\/D3-and-D5-300x230.png 300w, https:\/\/fertiga.com\/wp-content\/uploads\/2025\/09\/D3-and-D5-768x588.png 768w, https:\/\/fertiga.com\/wp-content\/uploads\/2025\/09\/D3-and-D5-16x12.png 16w\" sizes=\"auto, (max-width: 289px) 100vw, 289px\" \/><\/a>\n<figcaption class=\"wp-element-caption\">Resultados del estudio con pacientes sometidas a transferencia selectiva de un solo embri\u00f3n (eSET) e ICSI.<\/figcaption>\n<\/figure>\n<p>Los resultados de nuestro \u00faltimo estudio prospectivo de intervenci\u00f3n mostraron que en el grupo de prueba Aurora niPCT\u2122 (tambi\u00e9n llamado prueba Aurora) con transferencia de un solo embri\u00f3n (SET) en el d\u00eda 3, la <strong>tasa de embarazo cl\u00ednico aument\u00f3 significativamente <\/strong>del 27 % al 63 % en el primer ciclo de transferencia en fresco. En comparaci\u00f3n con la SET en el d\u00eda 5, el aumento fue del 43 % al 63 %. Adem\u00e1s, <strong>se detect\u00f3 un aumento significativo en la tasa de nacidos vivos<\/strong> entre las transferencias del d\u00eda 3. Estas fueron pacientes de ICSI estimuladas con HP-hMG. En los grupos de control, las pacientes solo recibieron una evaluaci\u00f3n morfol\u00f3gica. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30627993\/\" target=\"_blank\" rel=\"noreferrer noopener\">Leer m\u00e1s\u2026<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Aumento de la tasa acumulada de embarazos<\/strong><\/p>\n<p>En un estudio cl\u00ednico anterior, se realiz\u00f3 un seguimiento de las tasas acumuladas y la prueba Aurora niPCT\u2122 tambi\u00e9n <strong>aument\u00f3 significativamente la tasa de embarazo acumulada<\/strong> del 56% al 78% en comparaci\u00f3n con el grupo de control del d\u00eda 3 cuando la paciente se someti\u00f3 a ciclos consecutivos. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33608027\/\" target=\"_blank\" rel=\"noreferrer noopener\">Leer m\u00e1s\u2026<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Mayor tasa de embarazo en el primer intento y menor tiempo para lograr el embarazo.<\/strong><\/p>\n<p>&nbsp;<\/p>\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full is-resized\"><a href=\"https:\/\/fertiga.com\/wp-content\/uploads\/2025\/10\/time-to.png\"><img loading=\"lazy\" decoding=\"async\" width=\"822\" height=\"758\" src=\"https:\/\/fertiga.com\/wp-content\/uploads\/2025\/10\/time-to.png\" alt=\"Results of clinical study showed a significantly shorter time-to-pregnancy. \" class=\"wp-image-1296\" style=\"width:300px;height:auto\" srcset=\"https:\/\/fertiga.com\/wp-content\/uploads\/2025\/10\/time-to.png 822w, https:\/\/fertiga.com\/wp-content\/uploads\/2025\/10\/time-to-300x277.png 300w, https:\/\/fertiga.com\/wp-content\/uploads\/2025\/10\/time-to-768x708.png 768w, https:\/\/fertiga.com\/wp-content\/uploads\/2025\/10\/time-to-13x12.png 13w\" sizes=\"auto, (max-width: 767px) 89vw, (max-width: 1000px) 54vw, (max-width: 1071px) 543px, 580px\" \/><\/a><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n<p>Los resultados de nuestro estudio cl\u00ednico mostraron un <strong>tiempo de embarazo significativamente menor<\/strong> en el grupo de la prueba Aurora niPCT\u2122 con transferencia de un solo embri\u00f3n (SET) en fresco o congelado, en comparaci\u00f3n con el grupo de control. Al considerar a todas las pacientes con al menos dos embriones transferibles, se necesitaron tres transferencias adicionales en el grupo de control para lograr el mismo embarazo cl\u00ednico.\u00a0 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33608027\/\" target=\"_blank\" rel=\"noreferrer noopener\">Leer m\u00e1s\u2026<\/a><\/p>\n<p>&nbsp;<\/p>\n\n\n<h2 class=\"wp-block-heading\">Principio basado en la ciencia<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La prueba Aurora niPCT\u2122 se realiza en las c\u00e9lulas del c\u00famulo que rodean los ovocitos de una paciente y se basa en la medici\u00f3n de la expresi\u00f3n de genes espec\u00edficos. <strong>Cumulus cells are individually removed<\/strong> from each oocyte and RNA is extracted from the cumulus cells. Real-time PCR is performed for predictive genes and two control genes that leads to a quantitative ranking for all oocytes. Find out more:<\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-1391f922-c552-481c-8f3b-96cfcf582df5\" href=\"https:\/\/fertiga.com\/wp-content\/uploads\/2026\/06\/Aurora-niPCT-Brochure.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Aurora niPCT\u2122 Brochure ENG<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-a6e48bad-241e-431c-97b6-86414e58f440\" href=\"https:\/\/fertiga.com\/wp-content\/uploads\/2026\/06\/DU-niPCT-Brochure_clinicians.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Aurora niPCT\u2122 Brochure NL<\/a><\/div>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-607f2cae-6e75-4bf4-9a98-d2af80f53753\" href=\"https:\/\/fertiga.com\/wp-content\/uploads\/2026\/06\/FR-niPCT-Brochure_clinicians.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Aurora niPCT\u2122 Brochure FR<\/a><\/div>\n\n\n\n<h1 class=\"wp-block-heading\">Aurora niPCT\u2122 es aplicable para<\/h1>\n\n\n\n<ul class=\"wp-block-list\">\n<li>transferencias frescos<\/li>\n\n\n\n<li>transferencias congeladas<\/li>\n\n\n\n<li>ciclos de donaci\u00f3n<\/li>\n\n\n\n<li>criopreservaci\u00f3n social de ovocitos<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">La prueba Aurora niPCT\u2122 se realiza en las c\u00e9lulas del c\u00famulo de todos los ovocitos de una paciente y sigue el mismo protocolo de an\u00e1lisis molecular que para una paciente de ICSI. Los ovocitos se clasifican y, posteriormente, se priorizan los mejor clasificados. Los ovocitos deben congelarse individualmente. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38295095\/\" target=\"_blank\" rel=\"noreferrer noopener\">Leer m\u00e1s<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Cronograma del servicio Aurora niPCT\u2122<\/h2>\n\n\n<div class=\"wp-block-image wp-block-image aligncenter size-large\">\n<figure ><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"345\" src=\"https:\/\/fertiga.com\/wp-content\/uploads\/2026\/05\/Yellow-and-Orange-Illustrative-Self-Improvement-Infographic-Poster-1-1-1024x345.png\" alt=\"\" class=\"wp-image-1641\" srcset=\"https:\/\/fertiga.com\/wp-content\/uploads\/2026\/05\/Yellow-and-Orange-Illustrative-Self-Improvement-Infographic-Poster-1-1-1024x345.png 1024w, https:\/\/fertiga.com\/wp-content\/uploads\/2026\/05\/Yellow-and-Orange-Illustrative-Self-Improvement-Infographic-Poster-1-1-300x101.png 300w, https:\/\/fertiga.com\/wp-content\/uploads\/2026\/05\/Yellow-and-Orange-Illustrative-Self-Improvement-Infographic-Poster-1-1-768x259.png 768w, https:\/\/fertiga.com\/wp-content\/uploads\/2026\/05\/Yellow-and-Orange-Illustrative-Self-Improvement-Infographic-Poster-1-1-18x6.png 18w, https:\/\/fertiga.com\/wp-content\/uploads\/2026\/05\/Yellow-and-Orange-Illustrative-Self-Improvement-Infographic-Poster-1-1.png 1536w\" sizes=\"auto, (max-width: 767px) 89vw, (max-width: 1000px) 54vw, (max-width: 1071px) 543px, 580px\" \/><figcaption class=\"wp-element-caption\">Timetable for a fresh eSET<\/figcaption><\/figure>\n<\/div>\n\n<\/p>\n<p><!-- \/wp:post-content --><\/p>\n<p><!-- wp:paragraph --><\/p>\n<p>En caso de que no se produzca un embarazo tras la primera transferencia, los embriones supernumerarios que fueron vitrificados individualmente tambi\u00e9n se transferir\u00e1n seg\u00fan la puntuaci\u00f3n Aurora.<\/p>\n<p><!-- \/wp:paragraph --><\/p>\n<p><!-- wp:paragraph --><\/p>\n<p>Si se programa una transferencia de eSET congelada, las muestras se pueden enviar m\u00e1s tarde, pero deben llegar al laboratorio de pruebas cl\u00ednicas de Fertiga al menos una semana antes de la transferencia.<\/p>\n<p><!-- \/wp:paragraph --><\/p>\n<p><!-- wp:file {\"id\":1594,\"href\":\"https:\/\/fertiga.com\/wp-content\/uploads\/2026\/04\/Blue-and-White-Modern-Pharmacy-Lab-Flyer-7.pdf\",\"showDownloadButton\":false,\"displayPreview\":false,\"previewHeight\":670} --><\/p>\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-a2751fe1-b2a3-41ed-a0e0-3f5eb5fdbc22\" href=\"https:\/\/fertiga.com\/wp-content\/uploads\/2026\/04\/Blue-and-White-Modern-Pharmacy-Lab-Flyer-7.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Un folleto con informaci\u00f3n m\u00e1s detallada sobre el flujo de trabajo en el laboratorio de embriolog\u00eda. <\/a><\/div>\n<p><!-- \/wp:file --><\/p>\n<p><!-- wp:paragraph --><\/p>\n<p>Si desea obtener m\u00e1s informaci\u00f3n sobre la <strong>estandarizaci\u00f3n de las condiciones preanal\u00edticas para realizar pruebas fiables y no invasivas de c\u00e9lulas del c\u00famulo antes de la implantaci\u00f3n, p\u00f3ngase en<\/strong>, <a href=\"https:\/\/fertiga.com\/es\/contact-us\/\" type=\"link\" id=\"https:\/\/fertiga.com\/contact-us\/\">contacto con nosotros<\/a> para solicitar un informe t\u00e9cnico.<\/p>\n<p><!-- \/wp:paragraph --><\/p>\n<p><!-- wp:heading --><\/p>\n<h2 class=\"wp-block-heading\">Our research<\/h2>\n<p><!-- \/wp:heading --><\/p>\n<p><!-- wp:list {\"ordered\":true} --><\/p>\n<ol class=\"wp-block-list\"><!-- wp:list-item --><\/p>\n<li>Adriaenssens T, Van Vaerenbergh I, Van Leuven W, Coucke W, Montenegro S, Zheng W, D\u2019Hooghe T, Van Landuyt L, De Munck N, Van Hecke E, Smitz J, Rosenthal A, Blockeel C<em>.<\/em>Live birth in patients stimulated with r-hFSH or r-hFSH: r-hLH is strongly associated with cumulus cell derived gene expression models.\u00a0Reprod Biol Endocrinol.\u00a02025;23(163). <a href=\"https:\/\/doi.org\/10.1186\/s12958-025-01480-2\">doi:1186\/s12958-025-01480-2<\/a><\/li>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- wp:list-item --><\/p>\n<li>Van Vaerenbergh I, Adriaenssens T, Coucke W, Van Landuyt L, Verheyen G, De Brucker M, Camus M, Platteau P, De Vos M, Van Hecke E, Rosenthal A, Smitz J. Improved clinical outcomes after non-invasive oocyte selection and Day 3 eSET in ICSI patients. Reprod Biol Endocrinol. 2021;19(1):26. doi: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33608027\/\">1186\/s12958-021-00704-5<\/a><\/li>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- wp:list-item --><\/p>\n<li>Adriaenssens T, Van Vaerenbergh I, Coucke W, Segers I, Verheyen G, Anckaert E, De Vos M, Smitz J. Cumulus-corona gene expression analysis combined with morphological embryo scoring in single embryo transfer cycles increases live birth after fresh transfer and decreases time to pregnancy. J Assist Reprod Genet. 2019;36(3):433-443. doi: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30627993\/\">1007\/s10815-018-01398-2<\/a><\/li>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- wp:list-item --><\/p>\n<li>Wathlet S, Adriaenssens T, Segers I, Verheyen G, Van Landuyt L, Coucke W, Devroey P, Smitz J. Pregnancy prediction in single embryo transfer cycles after ICSI using QPCR: validation in oocytes from the same cohort. PLoS One. 2013;8(4):e54226. doi: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23573182\/\">1371\/journal.pone.0054226<\/a><\/li>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- wp:list-item --><\/p>\n<li>Wathlet S, Adriaenssens T, Segers I, Verheyen G, Janssens R, Coucke W, Devroey P, Smitz J. New candidate genes to predict pregnancy outcome in single embryo transfer cycles when using cumulus cell gene expression. Fertil Steril. 2012;98(2):432-9.e1-4. doi: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22633264\/\">1016\/j.fertnstert.2012.05.007<\/a><\/li>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- wp:list-item --><\/p>\n<li>Wathlet S, Adriaenssens T, Segers I, Verheyen G, Van de Velde H, Coucke W, Ron El R, Devroey P, Smitz J. Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients. Hum Reprod. 2011;26(5):1035-51. doi: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21372047\/\">1093\/humrep\/der036<\/a><\/li>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- wp:list-item --><\/p>\n<li>Adriaenssens T, Segers I, Wathlet S, Smitz J. The cumulus cell gene expression profile of oocytes with different nuclear maturity and potential for blastocyst formation. J Assist Reprod Genet. 2011;28(1):31-40. doi: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20859762\/\">1007\/s10815-010-9481-9<\/a><\/li>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- wp:list-item --><\/p>\n<li>Adriaenssens T, Wathlet S, Segers I, Verheyen G, De Vos A, Van der Elst J, Coucke W, Devroey P, Smitz J. Cumulus cell gene expression is associated with oocyte developmental quality and influenced by patient and treatment characteristics. Hum Reprod. 2010;25(5):1259-70. doi: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20228394\/\">1093\/humrep\/deq049<\/a><\/li>\n<p><!-- \/wp:list-item --><\/ol>\n<p><!-- \/wp:list --><\/p>","protected":false},"excerpt":{"rendered":"<p>Not all oocytes are equal\u2026 but now you can tell which ones will thrive The Aurora niPCT\u2122 is the first clinically proven, non-invasive test that looks at what truly matters: the oocyte\u2019s biological potential itself. By analysing the cumulus cells that naturally surround and support the egg, Aurora niPCT\u2122 decodes the molecular signals of highest &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/fertiga.com\/es\/increased-live-birth-rate-2\/\" class=\"more-link\">Continuar leyendo<span class=\"screen-reader-text\"> &#8220;For healthcare providers&#8221;<\/span><\/a><\/p>","protected":false},"author":4,"featured_media":62,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-20","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>For healthcare providers - Fertiga<\/title>\n<meta name=\"description\" content=\"Increased live birth and pregnancy rates with Aurora niPCT\u2122! This non-invasive preimplantation test can help you select the best embryo at the first try.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fertiga.com\/es\/increased-live-birth-rate-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"For healthcare providers - Fertiga\" \/>\n<meta property=\"og:description\" content=\"Increased live birth and pregnancy rates with Aurora niPCT\u2122! This non-invasive preimplantation test can help you select the best embryo at the first try.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fertiga.com\/es\/increased-live-birth-rate-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Fertiga\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FertigaFertility\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-04T08:12:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fertiga.com\/wp-content\/uploads\/2018\/09\/shutterstock_324159947-1024x683.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fertiga.com\\\/increased-live-birth-rate-2\\\/\",\"url\":\"https:\\\/\\\/fertiga.com\\\/increased-live-birth-rate-2\\\/\",\"name\":\"For healthcare providers - Fertiga\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fertiga.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fertiga.com\\\/increased-live-birth-rate-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fertiga.com\\\/increased-live-birth-rate-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fertiga.com\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/shutterstock_324159947.jpg\",\"datePublished\":\"2018-08-31T08:43:31+00:00\",\"dateModified\":\"2026-06-04T08:12:33+00:00\",\"description\":\"Increased live birth and pregnancy rates with Aurora niPCT\u2122! This non-invasive preimplantation test can help you select the best embryo at the first try.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fertiga.com\\\/increased-live-birth-rate-2\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fertiga.com\\\/increased-live-birth-rate-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fertiga.com\\\/increased-live-birth-rate-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fertiga.com\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/shutterstock_324159947.jpg\",\"contentUrl\":\"https:\\\/\\\/fertiga.com\\\/wp-content\\\/uploads\\\/2018\\\/09\\\/shutterstock_324159947.jpg\",\"width\":3000,\"height\":2000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fertiga.com\\\/increased-live-birth-rate-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fertiga.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"For healthcare providers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fertiga.com\\\/#website\",\"url\":\"https:\\\/\\\/fertiga.com\\\/\",\"name\":\"Fertiga\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/fertiga.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fertiga.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fertiga.com\\\/#organization\",\"name\":\"Fertiga\",\"url\":\"https:\\\/\\\/fertiga.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fertiga.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/fertiga.com\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/logo.png\",\"contentUrl\":\"http:\\\/\\\/fertiga.com\\\/wp-content\\\/uploads\\\/2018\\\/04\\\/logo.png\",\"width\":487,\"height\":179,\"caption\":\"Fertiga\"},\"image\":{\"@id\":\"https:\\\/\\\/fertiga.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/FertigaFertility\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/fertiga\\\/\",\"https:\\\/\\\/www.instagram.com\\\/fertilitybyfertiga\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"For healthcare providers - Fertiga","description":"Increased live birth and pregnancy rates with Aurora niPCT\u2122! This non-invasive preimplantation test can help you select the best embryo at the first try.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fertiga.com\/es\/increased-live-birth-rate-2\/","og_locale":"es_ES","og_type":"article","og_title":"For healthcare providers - Fertiga","og_description":"Increased live birth and pregnancy rates with Aurora niPCT\u2122! This non-invasive preimplantation test can help you select the best embryo at the first try.","og_url":"https:\/\/fertiga.com\/es\/increased-live-birth-rate-2\/","og_site_name":"Fertiga","article_publisher":"https:\/\/www.facebook.com\/FertigaFertility","article_modified_time":"2026-06-04T08:12:33+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/fertiga.com\/wp-content\/uploads\/2018\/09\/shutterstock_324159947-1024x683.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fertiga.com\/increased-live-birth-rate-2\/","url":"https:\/\/fertiga.com\/increased-live-birth-rate-2\/","name":"For healthcare providers - Fertiga","isPartOf":{"@id":"https:\/\/fertiga.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fertiga.com\/increased-live-birth-rate-2\/#primaryimage"},"image":{"@id":"https:\/\/fertiga.com\/increased-live-birth-rate-2\/#primaryimage"},"thumbnailUrl":"https:\/\/fertiga.com\/wp-content\/uploads\/2018\/09\/shutterstock_324159947.jpg","datePublished":"2018-08-31T08:43:31+00:00","dateModified":"2026-06-04T08:12:33+00:00","description":"Increased live birth and pregnancy rates with Aurora niPCT\u2122! This non-invasive preimplantation test can help you select the best embryo at the first try.","breadcrumb":{"@id":"https:\/\/fertiga.com\/increased-live-birth-rate-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fertiga.com\/increased-live-birth-rate-2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fertiga.com\/increased-live-birth-rate-2\/#primaryimage","url":"https:\/\/fertiga.com\/wp-content\/uploads\/2018\/09\/shutterstock_324159947.jpg","contentUrl":"https:\/\/fertiga.com\/wp-content\/uploads\/2018\/09\/shutterstock_324159947.jpg","width":3000,"height":2000},{"@type":"BreadcrumbList","@id":"https:\/\/fertiga.com\/increased-live-birth-rate-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fertiga.com\/"},{"@type":"ListItem","position":2,"name":"For healthcare providers"}]},{"@type":"WebSite","@id":"https:\/\/fertiga.com\/#website","url":"https:\/\/fertiga.com\/","name":"Fertiga","description":"","publisher":{"@id":"https:\/\/fertiga.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fertiga.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/fertiga.com\/#organization","name":"Fertiga","url":"https:\/\/fertiga.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fertiga.com\/#\/schema\/logo\/image\/","url":"http:\/\/fertiga.com\/wp-content\/uploads\/2018\/04\/logo.png","contentUrl":"http:\/\/fertiga.com\/wp-content\/uploads\/2018\/04\/logo.png","width":487,"height":179,"caption":"Fertiga"},"image":{"@id":"https:\/\/fertiga.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FertigaFertility","https:\/\/www.linkedin.com\/company\/fertiga\/","https:\/\/www.instagram.com\/fertilitybyfertiga\/"]}]}},"_links":{"self":[{"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/pages\/20","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/comments?post=20"}],"version-history":[{"count":87,"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/pages\/20\/revisions"}],"predecessor-version":[{"id":1715,"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/pages\/20\/revisions\/1715"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/media\/62"}],"wp:attachment":[{"href":"https:\/\/fertiga.com\/es\/wp-json\/wp\/v2\/media?parent=20"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}